Alonso-Ruiz, Alberto <br/><br/>
Tumor necrosis factor alpha drugs in rheumatoid arthritis: systematic review and metaanalysis of efficacy and safety.  [electronic resource] 

 -  BMC musculoskeletal disorders  Apr 2008 
 - 52 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1471-2474 
<br/><br/><label>Standard No.: </label>10.1186/1471-2474-9-52  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Humanized<br/>Antirheumatic Agents--therapeutic use<br/>Arthritis, Rheumatoid--drug therapy<br/>Dose-Response Relationship, Drug<br/>Etanercept<br/>Humans<br/>Immunoglobulin G--therapeutic use<br/>Infliximab<br/>Methotrexate--therapeutic use<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Treatment Outcome<br/>Tumor Necrosis Factor-alpha--therapeutic use